Skip to main content
SpringerLink
Log in

Immunotherapy of neoplastic diseases with neuraminidase: Contradictions, new aspects, and revised concepts

  • General Review
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The divergent experimental results in immunotherapy of spontaneous, chemically induced or virus-induced solid tumors or leukemias with neuraminidase are reviewed and analyzed under the various aspects of the possible modes and conditions of action of the enzyme: Immunocompetence of the host, animal residual tumor volume, enzymatic activity of the neuraminidase, and identity of the antigenic specificity within the tumor system are well-known prerequisites for an effective tumor immunotherapy. In addition, there seems to be evidence that the number of tumor cells used for vaccination and the dose of enzymatically active VCN, whether bound to VCN-treated tumor cells or injected intratumorally, may be decisive in the negative or positive outcome. Moreover, there are indications that a preexistent sensitization against the so-called Thomsen-Friedenreich antigen, which seems to be unmasked after VCN treatment of cells, may influence the tumor therapeutic success. The effect of nonspecific immunostimulators given in addition to neuraminidase or to neuraminidase-treated cells is controversial. Thus, this combination cannot be recommended unless it is fully explored. To overcome the problem of the dependence of the tumor therapeutic effect on the dose of cells and the amount of neuraminidase with respect to different tumors and different adjuvant treatments, a new immunization concept, named ‘chessboard vaccination’, has been proposed. The data obtained so far in vitro and in vivo with this chessboard vaccination are briefly reviewed. They show that chessboard vaccination might be of diagnostic as well as of therapeutic interest.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Albright, L., Madigan, J. C., Gaston, M. R., Houchens, D. P.: Therapy in an intracerebral murine glioma model, using bacillus Calmette-Guérin, neuraminidase-treated tumor cells, and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Cancer Res. 35, 658 (1975)

    Google Scholar 

  • Alley, C. D., Snodgrass, M. J.: Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas. Cancer Res. 37, 95 (1977)

    Google Scholar 

  • Barinskii, I. F., Kobrinskii, G. D.: Inhibitory action of neuraminidase of Vibrio cholerae in Rauscher mouse leukemia. Byulleten Eksperimental 'noi Biologii i Meditziny 82, 1357 (1976); cited from UDC 616.155.392–085.372:576.851.315.097.29

    Google Scholar 

  • Barth, R. F., Singla, O.: Alterations in the immunogenicity and anti-genicity of mammalian erythrocytes following treatment with neuraminidase (3770). Proc. Soc. Exp. Biol. Med. 145, 168 (1974)

    Google Scholar 

  • Bekesi, J. G., Holland, J. F.: Active immunotherapy in leukemia with neuraminidase-modified leukemic cells. Recent Results Cancer Res. 62, 78 (1977)

    Google Scholar 

  • Bekesi, J. G., Holland, J. F.: Immunotherapy of acute myelocytic leukemia with neuraminidase-treated myeloblast and MER. Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 375. Stutgart, New York: Schattauer 1978

    Google Scholar 

  • Bekesi, J. G., St. Arneault, G., Holland, J. F.: Increase of leukemia L 1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res. 31, 2130 (1971)

    Google Scholar 

  • Bekesi, J. G., St. Arneault, G., Walter, L., Holland, J. F.: Immunogenicity of leukemia L 1210 cells after neuraminidase treatment. J. Natl. Cancer Inst. 49, 107 (1972)

    Google Scholar 

  • Bekesi, J. G., Roboz, J. P., Walter, L., Holland, J. F.: Stimulation of specific immunity against cancer by neuraminidase-treated tumor cells. Behring Inst. Mitt. 55, 309 (1974)

    Google Scholar 

  • Bekesi, J. G., Roboz, J. P., Holland, J. F.: Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia. Ann. N.Y. Acad. Sci. 277, 313 (1976)

    Google Scholar 

  • Binder, P., Perrot, L., Beaudry, Y., Bottex, C., Fontanges, R.: Cancérologie. — Etude, chez le Rat, des effets de la neuraminidase, bactérienne et virale, en injection intratumorale. C. R. Acad. Sci. [D] Paris 281, 1545 (1975)

    Google Scholar 

  • Bliznakov, E. G.: Immunostimulation or immunodepression? Biomedicine 26, 73 (1977)

    Google Scholar 

  • Cook, G. M., Jacobson, W.: The electrophoretic mobility of normal and leukaemic cells of mice. Biochem. J. 107, 549 (1968)

    Google Scholar 

  • Currie, G. A.: Masking of antigens on the Landschütz ascites tumor. Lancet 1967 II, 1336

    Google Scholar 

  • Currie, G. A., Bagshawe, K. D.: The effect of neuraminidase on the immunogenicity of the Landschütz ascites tumor. Site and mode of action. Br. J. Cancer 22, 588 (1968a)

    Google Scholar 

  • Currie, G. A., Bagshawe, K. D.: The role of sialic acid in antigenic expression: Further studies of the Landschütz ascites tumor. Br. J. Cancer 22, 843 (1968b)

    Google Scholar 

  • Doré, J. F., Hadjiyannakis, M. J., Guibout, C., Coudert, A., Marholev, L., Imai, K.: Use of enzyme-treated cells in immunotherapy of a murine leukemia. Lancet 1973 VIII, 600

    Google Scholar 

  • Egeberg, J., Jensen, O. A.: The effect of neuraminidase-treated tumor cells on the growth of transplantable malignant melanoma of the Syrian golden hamster (mesocricetus auratus). Int. Rev. Cytol. [Suppl.] 2, 1573 (1974)

    Google Scholar 

  • Eisenberg, S., Ben-Or, S., Dolanski, F.: Electrokinetic properties of cells in growth processes. I. The electronic behavior of liver cells during regeneration and postnatal growth. Exp. Res. 26, 451 (1962)

    Google Scholar 

  • Fidler, I. J., Kahn, J. M., Montgomery, P. C.: Effect of neuraminidase on the rat one-way mixed lymphocyte interaction. Immunol. Commun. 2 573 (1973)

    Google Scholar 

  • Flye, M. W., Reisner, E. G., Amos, D. B.: The in vitro effect of neuraminidase on human lymphocytes. J. Surg. Res. 15 (1973)

  • Friedenreich, V.: Untersuchungen über das von O. Thomsen beschriebene vermehrungsfähige Agens als Veränderer des isoagglutinatorischen Verhaltens der roten Blutkörperchen. Z. Immunitaetsforsch. 55, 84 (1928)

    Google Scholar 

  • Friedenreich, V.: Die serologische Auffassung des Thomsenschen Blutkörperchenreceptors. Acta Pathol. Microbiol. Scand. [Suppl.] V, 68 (1930)

    Google Scholar 

  • Froese, G., Berczi, I., Sehon, A. H.: Brief communication: Neuraminidase-induced enhancement of tumor growth in mice. J. Natl. Cancer Inst. 52, 1905 (1974)

    Google Scholar 

  • Gautam, S., Aikat, B. K.: Immunotherapy of methylcholanthrene-induced and spontaneous tumours in mice by use of tumor vaccine, neuraminidase and BCG. Indian J. Med. Res. 64, 3 (1976)

    Google Scholar 

  • Ghose, T., Guclu, A., Tai, J., Mammen, M., Norvell, S. T.: Immunoprophylaxis and immunotherapy of EL4 lymphoma. Eur. J. Cancer 13, 925 (1977)

    Google Scholar 

  • Girard, J. P., Fernandes, B.: Studies on the mitogenic activity of trypsin, pronase and neuraminidase on human peripheral blood lymphocytes. Eur. J. Clin. Invest. 6, 347 (1976)

    Google Scholar 

  • Gottschalk, A.: Neuraminidase: Its substrate and mode of action. Adv. Enzymol. 20, 135 (1958)

    Google Scholar 

  • Grimes, W. J.: Sialic acid transferases and sialic acid levels in normal and transformed cells. Biochem. J. 9, 5083 (1970)

    Google Scholar 

  • Grothaus, E. A., Flye, M. W., Yunis, E., Amos, B. D.: Human lymphocyte antigen reactivity modified by neuraminidase. Science 173, 54 (1971)

    Google Scholar 

  • Haegert, D. G.: Neuraminidase- and trypsin-induced exposure of membrane receptors for IgG and IgM molecules on human peripheral blood lymphocytes. Clin. Exp. Immunol. 29, 457 (1977)

    Google Scholar 

  • Hakamori, S.: In: 22nd Colloquium of the Gesellschaft für Biologische Chemie. Wallach, D. F. H., Fischer, H. (eds.), pp. 65. New York, Heidelberg, Berlin: Springer 1971

    Google Scholar 

  • Hakamori, S., Murakami, W. T.: Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines. Proc. Natl. Acad. Sci. USA 59, 254 (1968)

    Google Scholar 

  • Han, T.: Enhancement of mixed lymphocyte reactivity by neuraminidease. Transplantation 14, 515 (1972)

    Google Scholar 

  • Han, T.: Enhancement of delayed skin hypersensitivity by neuraminidase in cancer patients. Clin. Exp. Immunol. 18, 95 (1974)

    Google Scholar 

  • Han, T.: The effect of neuraminidase on cell-mediated immunity in vitro and in vivo in man. In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”. Stuttgart, New York: Schattauer 1978

    Google Scholar 

  • Hauschka, T. S., Weiss, L., Holridge, B. A.: Karyotypic and surface features of murine TA3 carcinoma cells during immunoselection in mice and rats. J. Natl. Cancer Inst. 47, 343 (1971)

    Google Scholar 

  • Holland, J. F., Bekesi, J. G.: Immunotherapy of human leukemia with neuraminidase-modified cells. Med. Clin. North Am. 60, 539 (1976)

    Google Scholar 

  • Hughes, R. C., Palmer, P. D., Sanford, B. H.: Factors involved in the cytotoxicity of normal guinea-pig serum for cells of murine tumor TA3 sublines treated with neuraminidase. J. Immunol. 111, 107 (1973)

    Google Scholar 

  • Jamieson, C. W.: Enhancement of antigenicity of syngeneic murine melanoma by neuraminidase. Int. Cancer Congress, Florence, 1974 (Workshop 1, Abstracts, p. 233)

  • Johannsen, R., Sedlacek, H. H.: Specificity of cytotoxic antibodies to autologous human lymphocytes treated with neuraminidase from Vibrio cholerae. Behring Inst. Mitt. 55, 209 (1974)

    Google Scholar 

  • Johannsen, R., Carlsson, A. B., Sedlacek, H. H.: In vitro transformation of human lymphocytes by neuraminidase from Vibrio cholerae (VCN). 6th Workshop on Leucocyte Cultures, Basel, March 17–19, 1975 (Abstracts, p. 86)

  • Johannsen, R., Knop, J., Sedlacek, H. H., Seiler, F. R.: Augmentation of in vitro lymphocyte response by neuraminidase. Z. Immunitaetsforsch. 152, 90 (1976)

    Google Scholar 

  • Johannsen, R., Sedlacek, H. H., Seiler, F. R.: Adjuvant effect of Vibrio cholerae neuraminidase on the in vitro and in vivo immune response. In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 244. Stuttgart, New York: Schattauer 1978a

    Google Scholar 

  • Johannsen, R., Sedlacek, H. H., Schmidtberger, R., Schick, H. J., Seiler, F. R.: Characteristics of cytotoxic antibodies against neuraminidase-treated lymphocytes in man. J. Natl. Cancer Inst. (In press, 1978b)

  • Kassulke, J. T., Stutman, O., Yunis, E. J.: Blood-group isoantigens in leukemic cells. Reversibility of isoantigenic changes by neuraminidase. J. Natl. Cancer Inst. 46, 1201 (1971)

    Google Scholar 

  • Keenan, T. W., Morré, D. J.: Mammary carcinoma: Enzymatic block in disialoganglioside biosynthesis. Science 182, 935 (1973)

    Google Scholar 

  • Killion, G. J.: The immunotherapeutic value of a L 1210 tumor cell vaccine depends upon the expression of cell-surface carbohydrates. Cancer Immunol. Immunother. 3, 87 (1977)

    Google Scholar 

  • Kim, Z., Uhlenbruck, G.: Untersuchungen über T-Antigen und T-Agglutinin. Z. Immunitaetsforsch. 130, 88 (1966)

    Google Scholar 

  • Klein, P. J., Newmann, R. A., Müller, P., Uhlenbruck, G., Schaefer, H. E., Lennartz, K. J., Fischer, R.: Histochemical methods for the demonstration of Thomsen-Friedenreich antigen in cell suspensions and tissue sections. Klin. Wochenschr. 56, 761 (1978a)

    Google Scholar 

  • Klein, P. J., Newman, R. A., Müller, P., Uhlenbruck, G., Citoler, P., Schaefer, H. E., Lennartz, K. J., Fischer, R.: The presence and significance of the Thomsen-Friedenreich antigen in breast tissue. II. Its topochemistry in normal, hyperplastic and carcinoma tissue of the breast. Cancer Res. Clin. Oncol. (In press, 1978b)

  • Klein, P. J., Newman, R. A., Müller, P., Schaefer, H. E., Lennartz, K. J., Uhlenbruck, G., Fischer, R.: Verteilung des sog. Thomsen-Friedenreich-Antigens in normalem, mastopathischem und karzinomatösen Mammagewebe. Verh. Dtsch. Ges. Pathol. (In press, 1978c)

  • Knop, J., Sedlacek, H. H., Seiler, F. R.: Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response against various antigens. Immunology 34, 181 (1978a)

    Google Scholar 

  • Knop, J., Ax, W., Sedlacek, H. H., Seiler, F. R.: Effect of Vibrio cholerae neuraminidase on the phagocytosis of E. coli by macrophages in vivo and in vitro. Immunology, 34, 555 (1978b)

    Google Scholar 

  • Kollmorgen, G. M., Killion, J. J., Sansing, W. A., Cantrell, J. I., Bundren, J. C., LeFever, A. V.: Immunotherapy with neuraminidase-treated cells and bacillus Calmette-Guérin. Surgery 79, 202 (1976)

    CAS  PubMed  Google Scholar 

  • Landsteiner, K., Levine, P.: On individual differences in human blood. J. Exp. Med. 47, 757 (1928)

    Google Scholar 

  • LeFever, A. V., Killion, J. J., Kollmorgen, G. M.: Active immunotherapy of L 1210 leukemia with neuraminidase-treated, drug-resistant L 1210 sublines. Cancer Immunol. Immunother. 1, 211 (1976)

    Google Scholar 

  • Lindenmann, J., Klein, P. A.: Immunological aspects of viral oncolysis. Recent Results Cancer Res. 9, 66 (1967)

    Google Scholar 

  • Lüben, G., Sedlacek, H. H., Seiler, F. R.: Quantitative experiments on the cell membrane binding of neuraminidase. Behring Inst. Mitt. 59, 30 (1976)

    Google Scholar 

  • Mathé, G., Halle-Pannenko, O., Bourut, C.: Active immunotherapy of AKR mice with spontaneous leukemia. Rev. Eur. Études Clin. Biol. 17, 997 (1973)

    Google Scholar 

  • Mayhew, E.: Cellular electrophoretic mobility and the mitotic cycle. J. Gen. Physiol. 49, 717 (1966)

    Google Scholar 

  • Mayhew, E., Weiss, L.: Ribonucleic acid at the periphery of different cell types and effect of growth rate on ionogenic groups in the periphery cultured cells. Exp. Cell Res. 50, 441 (1968)

    Google Scholar 

  • Metzgar, R. S., Mohanakumar, T., Miller, D. S.: Antigens specific for human lymphocytic and myeloid leukemia cells: Detection of nonhuman primate antisera. Science 178, 986 (1972)

    Google Scholar 

  • Miller, C. W., DeBlasi, R. F., Fisher, S. J.: Immunological studies in murine osteosarcoma. J. Bone Joint Surg. [Am.] 58, 312 (1976)

    Google Scholar 

  • Nordling, S. E., Mayhew, E.: On the intracellular uptake of neuraminidase. Exp. Cell Res. 44, 552 (1966)

    Google Scholar 

  • Ohta, N., Pardee, A. B., McAuslan, B. R.: Sialic acid contents and controls of normal and malignant cells. Biochim. Biophys. Acta 158, 98 (1968)

    Google Scholar 

  • Petitou, M., Rosenfeld, C., Sinay, P.: A new assay for cell-bound neuraminidase. Cancer Immunol. Immunother. 2, 135 (1977)

    Google Scholar 

  • Pimm, M. V., Cook, A. J., Baldwin, R. W.: Failure of neuraminidase treatment to influence tumorigenicity or immunogenicity of syngeneically transplanted rat tumor cells. Eur. J. Cancer 14, 869 (1978)

    Google Scholar 

  • Porwit-Bobr, Z., Slowik, M., Tomecki, J.: Effect of neuraminidase-treated and mitomycin C-treated polyoma tumor cells on the established tumor growth in CBA mice. I. An attempt at evaluation of polyoma tumor destruction using the distribution of lissamine green method. Folia Histochem. Cytochem. (Krakow) 12, 315 (1974)

    Google Scholar 

  • Prokop, O., Uhlenbruck, G., Kühler, W.: A new source of antibody-like substances having anti-blood group specificity. Vox Sang. 14, 321 (1968)

    Google Scholar 

  • Ray, P. K., Simmons, R. L.: Failure of neuraminidase to unmask allogeneic antigens on cell surface. Proc. Soc. Exp. Biol. Med. 138, 600 (1971)

    Google Scholar 

  • Ray, P. K., Thakur, V. S., Sundaram, K.: Antitumor immunity. II. Viability, tumorgenicity and immunogenicity of neuraminidase-treated tumor cells: Effective immunization of animals with a tumor vaccine. J. Natl. Cancer Inst. 56, 83 (1976)

    Google Scholar 

  • Reed, R. C., Gutterman, J. U., Mavligit, G. M., Hersh, E. M.: Sialic acid on leukemia cells: Relation to morphology and tumor immunity (37896). Proc. Soc. Exp. Biol. Med. 145, 790 (1974)

    Google Scholar 

  • Reisner, E. G.: Relation of the neuraminidase-revealed antigens of human lymphocytes and erythrocytes. Transplantation 19, 359 (1975)

    Google Scholar 

  • Reisner, E. G., Amos, D. B.: The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase. Transplantation 14, 455 (1972)

    Google Scholar 

  • Reisner, E. G., Flye, K., Su Chung, S., Amos, D. B.: The cytotoxic reactivity and sialic acid content of human lymphoid cells. Tissue Antigens 4, 7 (1974)

    Google Scholar 

  • Rios, A., Simmons, R. L.: Comparative effect of mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice. Cancer Res. 3, 16 (1972)

    Google Scholar 

  • Rios, A., Simmons, R. L.: Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells. J. Natl. Cancer Inst. 51, 637 (1973)

    Google Scholar 

  • Rios, A., Simmons, R. L.: Active specific immunotherapy of minimal residual tumor: Excision plus neuraminidase-treated tumor cells. Int. J. Cancer 13, 71 (1974)

    CAS  PubMed  Google Scholar 

  • Rogentine, G. N., Jr.: Naturally occurring human antibody to neuraminidase-treated human lymphocytes. Antibody levels in normal subjects, cancer patients and subjects with immunodeficiency. J. Natl. Cancer Inst. 54, 1307 (1975)

    Google Scholar 

  • Rogentine, G. N., Jr., Plocinik, B. A.: Carbohydrate inhibition studies of the naturally occurring human antibody to neuraminidase-treated human lymphocytes. J. Immunol. 113, 3 (1974)

    Google Scholar 

  • Rogentine, G. N., Jr., Doherty, C. M., Pincus, S. H.: Increase in titer of the naturally occurring human antibody to neuraminidase-treated lymphocytes after influenza. J. Immunol. 119, 1652 (1977)

    Google Scholar 

  • Rosenberg, S. A., Rogentine, G. N., Jr.: Natural human antibodies to “hidden” membrane components. Nature [New Biol.] 239 (1972)

  • Rosenberg, S. A., Plocinik, B. A., Rogentine, G. N., Jr.: “Unmasking” of human lymphoid cell heteroantigens by neuraminidase treatment. J. Natl. Cancer Inst. 48, 1271 (1972)

    Google Scholar 

  • Rosenfeld, C., Pico, J. L., Petitou, M., Sharif, A., Choquet, C., Driancourt, C., Tuy, F.: Neuraminic acid and neuraminidase on the cell surface of human lymphoblastoid cell lines. In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 279. Stuttgart, New York: Schattauer 1978

    Google Scholar 

  • Ruhenstroth-Bauer, G., Fuhrmann, G. F., Gzanzek, E.: Elektrophoretische Untersuchungen an normalen und malignen Zellen. Naturwissenschaften 49, 363 (1962a)

    Google Scholar 

  • Ruhenstroth-Bauer, G., Fuhrmann, G. F., Kübler, W., Rueff, F., Munk, K.: Zur Bedeutung der Neuraminsäuren in der Zellmembran für das Wachstum maligner Zellen. Z. Krebsforsch. 65, 37 (1962b)

    Google Scholar 

  • Sanford, B. H.: An alteration in tumor host compatibility induced by neuraminidase. Transplantation 5, 1273 (1967)

    Google Scholar 

  • Sanford, B. H., Codington, J. F.: Alteration of the tumor cell surface by neuraminidase. Transplant. Proc. 3, 1155 (1971a)

    Google Scholar 

  • Sanford, B. H., Codington, J. F.: Further studies on the effect of neuraminidase on tumor cell transplantability. Tissue Antigens 1, 153 (1971b)

    Google Scholar 

  • Schlesinger, M., Amos, D. B.: The effect of neuraminidase on the serological properties of murine lymphoid cells. Transplant. Proc. 111, 895 (1971)

    Google Scholar 

  • Schlesinger, M., Galili, U.: Interactions of human T lymphocytes and normal killer cells with urinary bladder carcinoma cells. The effect of neuraminidase treatment of the lymphocytes. In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 260. Stuttgart, New York: Schattauer 1978

    Google Scholar 

  • Schlesinger, M., Gottesfeld, S.: The effect of neuraminidase on expression of cellular antigens. Transplant. Proc. 3, 1154 (1971)

    Google Scholar 

  • Sedlacek, H. H., Seiler, F. R.: Demonstration of Vibrio cholerae neuraminidase (VCN) on the surface of VCN-treated cells. Behring Inst. Mitt. 55, 254 (1974)

    Google Scholar 

  • Sedlacek, H. H., Seiler, F. R.: The effect of Vibrio cholerae neuraminidase (VCN) on the local and humoral immunological reaction of mice against SRBC. Z. Immunitaetsforsch. 153, 353 (1977)

    Google Scholar 

  • Sedlacek, H. H., Seiler, F. R.: Effect of Vibrio cholerae neuraminidase on the cellular immune response in vivo. In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 268. Stuttgart, New York: Schattauer 1978a

    Google Scholar 

  • Sedlacek, H. H., Seiler, F. R.: Spontaneous mammary tumors in mongrel dogs: A relevant model to demonstrate tumor therapeutical success by application of neuraminidase. Dev. Biol. Stand. 38, 399 (1978b)

    Google Scholar 

  • Sedlacek, H. H., Seiler, F. R.: Neuraminidase immunotherapy of spontaneous canine mammary tumors. In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 227. Stuttgart, New York: Schattauer 1978c

    Google Scholar 

  • Sedlacek, H. H., Meesmann, H., Seiler, F. R.: Regression of spontaneous mammary tumors in dogs after injection of neuraminidase-treated tumor cells. Int. J. Cancer 15, 409 (1975)

    Google Scholar 

  • Sedlacek, H. H., Bengelsdorff, H. J., Lemmer, A., Seiler, F. R.: Approaches to effective tumor immunotherapy with cells and the enzyme neuraminidase. In: Proceedings of the Sixth International Conference on Lymphatic Tissues and Germinal Centers in Immune Reactions. New York: Plenum Press (In press, 1978)

    Google Scholar 

  • Seiler, F. R., Sedlacek, H. H.: Alterations of immunological phenomena by neuraminidase: Marked rise in the number of lymphocytes forming rosettes or bearing immunoglobulin receptors. Behring Inst. Mitt. 55, 258 (1974)

    Google Scholar 

  • Seiler, F. R., Sedlacek, H. H.: Chessboard vaccination: A pertinent approach to immunotherapy of cancer with neuraminidase and tumor cells? In: Proceedings of the Symposium “Immunotherapy of Malignant Diseases”, p. 479. Stuttgart, New York: Schattauer 1978

    Google Scholar 

  • Seiler, F. R., Sedlacek, H. H., Kanzy, E. J., Lang, W.: Über die Brauchbarkeit immunologischer Nachweismethoden zur Differenzierung funktionell verschiedener Lymphozyten: Spontanrosetten, Komplementrezeptor-Rosetten und Immunglobulinrezeptoren. Behring Inst. Mitt. 52, 26 (1972)

    Google Scholar 

  • Seiler, F. R., Sedlacek, H. H., Lüben, G., Wiegandt, H.: Alteration of the lymphocyte surface by Vibrio cholerae neuraminidase, gangliosides and lysolecithins. Behring Inst. Mitt. 59, 22 (1976)

    Google Scholar 

  • Sethi, K. K., Brandis, H.: Neuraminidase-induced loss in the transplantability of murine leukemia L 1210, induction of immunoprotection and the transfer of induced immunity to normal DBA/2 mice by serum and peritoneal cells. Br. J. Cancer 27, 106 (1973)

    Google Scholar 

  • Simmons, R. L., Rios, A. L.: Immunotherapy of cancer: Immunospecific rejection of tumor in recipients of neuraminidase-treated tumor cells plus BCG. Science 174, 591 (1971)

    Google Scholar 

  • Simmons, R. L., Rios, A.: Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. III. Synergistic effect of BCG and neuraminidase-treated tumor cells. Ann. Surg. 176, 188 (1972)

    Google Scholar 

  • Simmons, R. L., Rios, A.: Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas. J. Immunol. 111, 1820 (1973)

    Google Scholar 

  • Simmons, R. L., Rios, A.: Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. V. Quantitative aspects of the experimental immunotherapeutic model. Isr. J. Med. Sci. 10, 925 (1974)

    Google Scholar 

  • Simmons, R. L., Rios, A.: Modified tumor cells in the immunotherapy of solid mammary tumors. Med. Clin. North Am. 60, 551 (1976)

    Google Scholar 

  • Simmons, R. L., Rios, A., Ray, P. K.: Mechanism of neuraminidase-induced antigen “unmasking”. Surg. Forum 21, 265 (1970)

    Google Scholar 

  • Simmons, R. L., Rios, A., Lundgren, G. et al.: Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. Surgery 70, 38 (1971a)

    Google Scholar 

  • Simmons, R. L., Lipschultz, M. L., Rios, A., Ray, P. K.: Failure of neuraminidase to unmask histocompatibility antigens on trophoblast. Nature [New Biol.] 231, 111 (1971b)

    Google Scholar 

  • Simmons, R. L., Rios, A., Ray, P. K.: Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase. Nature 23, 179 (1971c)

    Google Scholar 

  • Simmons, R. L., Rios, A., Ray, P. K., Lundgren, G.: Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice. J. Natl. Cancer Inst. 47, 1087 (1971d)

    Google Scholar 

  • Simmons, R. L., Rios, A., Kershey, J. H.: Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG. J. Surg. Res. 12, 57 (1972)

    Google Scholar 

  • Simmons, R. L., Auraha, G. V., Gunnarson, A., Grage, T. B., McKhams, C. F.: Active specific immunotherapy for advanced melanoma utilizing neuraminidase-treated autochthonous tumor cells. Terry, W. D., Windhorst, D. (eds.), p. 128. New York: Raven 1978

    Google Scholar 

  • Smith, D. F., Walborg, E. F.: Isolation and chemical characterization of cell surface sialoglycopeptide fractions during progression of rat ascites hepatoma AS-30D. Cancer Res. 32, 543 (1972)

    Google Scholar 

  • Song, C. W., Levitt, S. H.: Immunotherapy with neuraminidase-treated tumor cells after radiotherapy. Radiat. Res. 64, 485 (1975)

    Google Scholar 

  • Sparks, F. C., Breeding, J. H.: Tumor regression and enhancement resulting from immunotherapy with bacillus Calmette-Guérin and neuraminidase. Cancer Res. 34, 3262 (1974)

    Google Scholar 

  • Spence, R. J., Simon, R. M., Baker, A. R.: Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 60, 451 (1978)

    Google Scholar 

  • Springer, G. F., Desai, P. R.: Increase in anti-T titer scores of breast-carcinoma patients following mastectomy. Naturwissenschaften 62, 587 (1975a)

    Google Scholar 

  • Springer, G. F., Desai, P. R.: Depression of Thomsen-Friedenreich (anti-T) antibody in humans with breast carcinoma. Naturwissenschaften 62, 302 (1975b)

    Google Scholar 

  • Springer, G. F., Desai, P. R.: Human blood group MN and precursor specificities: Structural and biological aspects. Carbohydr. Res. 40, 183 (1975c)

    Google Scholar 

  • Springer, G. F., Desai, P. R., Banatwala, I.: Blood group MN-specific substances and precursors in normal and malignant human breast tissues. Naturwissenschaften 61, 457 (1974)

    Google Scholar 

  • Springer, G. F., Desai, P. R., Banatwala, I.: Brief communication: Blood group MN antigens and precursors in normal and malignant human breast glandular tissue. J. Natl. Cancer Inst. 54, 335 (1975)

    Google Scholar 

  • Springer, G. F., Desai, P. R., Yang, H. J., Schachter, H., Narasimhan, S.: Interrelations of blood group M and precursor specificities and their significance in human carcinoma. In: Human blood groups, p. 179. Basel: Karger 1977

    Google Scholar 

  • Thomsen, O.: Ein vermehrungsfähiges Agens als Veränderer des isoagglutinatorischen Verhaltens der roten Blutkörperchen, eine bisher unbekannte Quelle der Fehlbestimmungen. Z. Immunitaetsforsch. 52, 85 (1927)

    Google Scholar 

  • Uhlenbruck, G., Rothe, A.: Biological alterations of membrane-bound glycoproteins by neuraminidase treatment. Behring Inst. Mitt. 55, 177 (1974)

    Google Scholar 

  • Uhlenbruck, G., Pardoe, G. I., Bird, G. W. G.: On the specificity of lectins with a broad agglutination spectrum. II. Studies on the nature of the T-antigen and the specific receptors of the lectin of Arachis hypogoea (ground-nut). Z. Immunitaetsforsch. 138, 424 (1969)

    Google Scholar 

  • Weiss, L.: Neuraminidase, sialic acids, and cell interactions. J. Natl. Cancer Inst. 50, 3 (1973)

    Google Scholar 

  • Weiss, L., Hauschka, T. S.: Malignancy, electrophoretic mobilities and sialic acids at the electrokinetic surface of TA3 cells. Int. J. Cancer 6, 270 (1970)

    Google Scholar 

  • Wilson, R. E., Sonis, S. T., Godrick, E. A.: Neuraminidase as an adjunct in the treatment of residual systemic tumor with specific immune therapy. Behring Inst. Mitt. 55, 334 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Laboratories of Behringwerke AG, D-3550, Marburg/Lahn, Federal Republic of Germany

    H. H. Sedlacek & F. R. Seiler

Authors
  1. H. H. Sedlacek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. R. Seiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sedlacek, H.H., Seiler, F.R. Immunotherapy of neoplastic diseases with neuraminidase: Contradictions, new aspects, and revised concepts. Cancer Immunol Immunother 5, 153–163 (1978). https://doi.org/10.1007/BF00199623

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199623

Keywords

Search

Navigation